What is the level of liabilities of 3SBio this year?
3SBio has a debt balance of 9.59 B CNY this year.
3SBio Liabilities 2024
3SBio Liabilities
9.59 B CNY
Ticker
1530.HK
ISIN
KYG8875G1029
WKN
A14T7Q
In 2024, 3SBio's total liabilities amounted to 9.59 B CNY, a 5.59% difference from the 9.08 B CNY total liabilities in the previous year.
3SBio Aktienanalyse
What does 3SBio do?
3SBio Inc. is a biopharmaceutical company from China that specializes in the research, development, manufacturing, and marketing of biological products. It was founded in 1993 in Shenyang, a city in northeast China, and its headquarters are now in Beijing. 3SBio's business model is based on the development and manufacturing of biopharmaceuticals that are used to treat cancer, autoimmune diseases, and other serious illnesses. The company focuses on biological medicines such as proteins, antibodies, and peptides that are produced using genetic technology. 3SBio operates a wide range of business sectors, including the manufacturing and sale of biopharmaceutical products, the manufacturing and sale of generics and biosimilar products, and research and development in the biotechnology field. The company also has several subsidiaries and joint ventures, including 3SBio International Holding, Sunshine Guojian Pharmaceutical, and Target Pharma. A well-known product of 3SBio is erythropoietin (EPO), which is used in the treatment of anemia. The company also has a portfolio of other biopharmaceutical products that are used to treat cancer, autoimmune diseases, and other serious illnesses. The history of 3SBio goes back to 1993 when it was founded as Shenyang Sunshine Pharmaceutical. In 2001, the company was renamed "Shenyang Sunshine Pharmaceutical Co. Ltd. 3S Bio" and focused on biological therapy. In 2007, the company successfully listed on the Hong Kong Stock Exchange and received the name 3SBio. In 2013, the company was privatized and acquired by a consortium of Chinese investment companies. 3SBio has a strong presence in China and is also expanding into international markets. The company has distribution partnerships in Asia, Europe, and North America, and plans to enter more markets. Overall, 3SBio is a leading company in China in the field of biopharmaceuticals that focuses on the treatment of serious illnesses. The company aims to be a leader in research and development, as well as in the manufacturing and sale of innovative products, and to expand its presence in global markets. 3SBio ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing 3SBio's Liabilities
3SBio's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating 3SBio's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing 3SBio's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
3SBio's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in 3SBio’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about 3SBio stock
What were the liabilities of 3SBio compared to the previous year?
The liabilities of 3SBio have increased by 5.59% increased compared to the previous year.
What are the consequences of high debt for investors of 3SBio?
High liabilities can pose a risk for investors of 3SBio, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in 3SBio?
Low liabilities mean that 3SBio has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of 3SBio affect the company?
An increase in liabilities of 3SBio can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of 3SBio affect the company?
A decrease in the liabilities of 3SBio can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of 3SBio?
Some factors that can influence the liabilities of 3SBio include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of 3SBio so important for investors?
The liabilities of 3SBio are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can 3SBio take to modify the liabilities?
To change its liabilities, 3SBio can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does 3SBio pay?
Over the past 12 months, 3SBio paid a dividend of 0.1 CNY . This corresponds to a dividend yield of about 1.73 %. For the coming 12 months, 3SBio is expected to pay a dividend of 0.11 CNY.
What is the dividend yield of 3SBio?
The current dividend yield of 3SBio is 1.73 %.
When does 3SBio pay dividends?
3SBio pays a quarterly dividend. This is distributed in the months of July, July, July, August.
How secure is the dividend of 3SBio?
3SBio paid dividends every year for the past 0 years.
What is the dividend of 3SBio?
For the upcoming 12 months, dividends amounting to 0.11 CNY are expected. This corresponds to a dividend yield of 1.92 %.
In which sector is 3SBio located?
3SBio is assigned to the 'Health' sector.
Wann musste ich die Aktien von 3SBio kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of 3SBio from 8/5/2024 amounting to 0.25 CNY, you needed to have the stock in your portfolio before the ex-date on 7/22/2024.
When did 3SBio pay the last dividend?
The last dividend was paid out on 8/5/2024.
What was the dividend of 3SBio in the year 2023?
In the year 2023, 3SBio distributed 0.2 CNY as dividends.
In which currency does 3SBio pay out the dividend?
The dividends of 3SBio are distributed in CNY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von 3SBio
Our stock analysis for 3SBio Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of 3SBio Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
